Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Control of Type III Secretion System Effector/Chaperone Ratio Fosters Pathogen Adaptation to Host-Adherent Lifestyle.

Elbaz N, Socol Y, Katsowich N, Rosenshine I.

MBio. 2019 Sep 17;10(5). pii: e02074-19. doi: 10.1128/mBio.02074-19.

2.

Intraepithelial neutrophils in mammary, urinary and gall bladder infections.

Mintz D, Salamon H, Mintz M, Rosenshine I, Shpigel NY.

Vet Res. 2019 Jul 19;50(1):56. doi: 10.1186/s13567-019-0676-5.

3.

Enteropathogenic Escherichia coli remodels host endosomes to promote endocytic turnover and breakdown of surface polarity.

Kassa EG, Zlotkin-Rivkin E, Friedman G, Ramachandran RP, Melamed-Book N, Weiss AM, Belenky M, Reichmann D, Breuer W, Pal RR, Rosenshine I, Lapierre LA, Goldenring JR, Aroeti B.

PLoS Pathog. 2019 Jun 26;15(6):e1007851. doi: 10.1371/journal.ppat.1007851. eCollection 2019 Jun.

4.

A Ubiquitous Platform for Bacterial Nanotube Biogenesis.

Bhattacharya S, Baidya AK, Pal RR, Mamou G, Gatt YE, Margalit H, Rosenshine I, Ben-Yehuda S.

Cell Rep. 2019 Apr 9;27(2):334-342.e10. doi: 10.1016/j.celrep.2019.02.055. Epub 2019 Mar 28.

5.

Pathogenic E. coli Extracts Nutrients from Infected Host Cells Utilizing Injectisome Components.

Pal RR, Baidya AK, Mamou G, Bhattacharya S, Socol Y, Kobi S, Katsowich N, Ben-Yehuda S, Rosenshine I.

Cell. 2019 Apr 18;177(3):683-696.e18. doi: 10.1016/j.cell.2019.02.022. Epub 2019 Mar 28.

PMID:
30929902
6.

EspH Suppresses Erk by Spatial Segregation from CD81 Tetraspanin Microdomains.

Ramachandran RP, Vences-Catalán F, Wiseman D, Zlotkin-Rivkin E, Shteyer E, Melamed-Book N, Rosenshine I, Levy S, Aroeti B.

Infect Immun. 2018 Sep 21;86(10). pii: e00303-18. doi: 10.1128/IAI.00303-18. Print 2018 Oct.

7.

Type Three Secretion System-Dependent Microvascular Thrombosis and Ischemic Enteritis in Human Gut Xenografts Infected with Enteropathogenic Escherichia coli.

Nissim-Eliraz E, Nir E, Shoval I, Marsiano N, Nissan I, Shemesh H, Nagy N, Goldstein AM, Gutnick M, Rosenshine I, Yagel S, Shpigel NY.

Infect Immun. 2017 Oct 18;85(11). pii: e00558-17. doi: 10.1128/IAI.00558-17. Print 2017 Nov.

8.

Epithelial cells detect functional type III secretion system of enteropathogenic Escherichia coli through a novel NF-κB signaling pathway.

Litvak Y, Sharon S, Hyams M, Zhang L, Kobi S, Katsowich N, Dishon S, Nussbaum G, Dong N, Shao F, Rosenshine I.

PLoS Pathog. 2017 Jul 3;13(7):e1006472. doi: 10.1371/journal.ppat.1006472. eCollection 2017 Jul.

9.

Host cell attachment elicits posttranscriptional regulation in infecting enteropathogenic bacteria.

Katsowich N, Elbaz N, Pal RR, Mills E, Kobi S, Kahan T, Rosenshine I.

Science. 2017 Feb 17;355(6326):735-739. doi: 10.1126/science.aah4886.

PMID:
28209897
10.

A long-term epigenetic memory switch controls bacterial virulence bimodality.

Ronin I, Katsowich N, Rosenshine I, Balaban NQ.

Elife. 2017 Feb 7;6. pii: e19599. doi: 10.7554/eLife.19599.

11.

Bacterial pathogenesis: Cooperative immunomodulation.

Rosenshine I.

Nat Microbiol. 2016 Jun 24;1(7):16099. doi: 10.1038/nmicrobiol.2016.99. No abstract available.

PMID:
27572979
12.

Age-Dependent Susceptibility to Enteropathogenic Escherichia coli (EPEC) Infection in Mice.

Dupont A, Sommer F, Zhang K, Repnik U, Basic M, Bleich A, Kühnel M, Bäckhed F, Litvak Y, Fulde M, Rosenshine I, Hornef MW.

PLoS Pathog. 2016 May 9;12(5):e1005616. doi: 10.1371/journal.ppat.1005616. eCollection 2016 May.

13.

PafR, a novel transcription regulator, is important for pathogenesis in uropathogenic Escherichia coli.

Baum M, Watad M, Smith SN, Alteri CJ, Gordon N, Rosenshine I, Mobley HL, Amster-Choder O.

Infect Immun. 2014 Oct;82(10):4241-52. doi: 10.1128/IAI.00086-14. Epub 2014 Jul 28.

14.

Dynamics of expression and maturation of the type III secretion system of enteropathogenic Escherichia coli.

Yerushalmi G, Litvak Y, Gur-Arie L, Rosenshine I.

J Bacteriol. 2014 Aug;196(15):2798-806. doi: 10.1128/JB.00069-14. Epub 2014 May 16.

15.

Structure of GrlR-GrlA complex that prevents GrlA activation of virulence genes.

Padavannil A, Jobichen C, Mills E, Velazquez-Campoy A, Li M, Leung KY, Mok YK, Rosenshine I, Sivaraman J.

Nat Commun. 2013;4:2546. doi: 10.1038/ncomms3546.

PMID:
24092262
16.

Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli.

Lai Y, Rosenshine I, Leong JM, Frankel G.

Cell Microbiol. 2013 Nov;15(11):1796-808. doi: 10.1111/cmi.12179. Epub 2013 Sep 3. Review.

17.

Dynamics of the type III secretion system activity of enteropathogenic Escherichia coli.

Mills E, Baruch K, Aviv G, Nitzan M, Rosenshine I.

MBio. 2013 Jul 30;4(4). pii: e00303-13. doi: 10.1128/mBio.00303-13.

18.

In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Law RJ, Gur-Arie L, Rosenshine I, Finlay BB.

Cold Spring Harb Perspect Med. 2013 Mar 1;3(3):a009977. doi: 10.1101/cshperspect.a009977. Review.

19.

EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.

Berger CN, Crepin VF, Baruch K, Mousnier A, Rosenshine I, Frankel G.

MBio. 2012 Oct 2;3(5). pii: e00317-12. doi: 10.1128/mBio.00317-12. Print 2012.

20.

Cycling of Etk and Etp phosphorylation states is involved in formation of group 4 capsule by Escherichia coli.

Nadler C, Koby S, Peleg A, Johnson AC, Suddala KC, Sathiyamoorthy K, Smith BE, Saper MA, Rosenshine I.

PLoS One. 2012;7(6):e37984. doi: 10.1371/journal.pone.0037984. Epub 2012 Jun 4.

21.

Host proteasomal degradation generates amino acids essential for intracellular bacterial growth.

Price CT, Al-Quadan T, Santic M, Rosenshine I, Abu Kwaik Y.

Science. 2011 Dec 16;334(6062):1553-7. doi: 10.1126/science.1212868. Epub 2011 Nov 17.

22.

Bundle-forming pilus retraction enhances enteropathogenic Escherichia coli infectivity.

Zahavi EE, Lieberman JA, Donnenberg MS, Nitzan M, Baruch K, Rosenshine I, Turner JR, Melamed-Book N, Feinstein N, Zlotkin-Rivkin E, Aroeti B.

Mol Biol Cell. 2011 Jul 15;22(14):2436-47. doi: 10.1091/mbc.E11-01-0001. Epub 2011 May 25.

23.

The crystal structure of Escherichia coli group 4 capsule protein GfcC reveals a domain organization resembling that of Wza.

Sathiyamoorthy K, Mills E, Franzmann TM, Rosenshine I, Saper MA.

Biochemistry. 2011 Jun 21;50(24):5465-76. doi: 10.1021/bi101869h. Epub 2011 May 27.

PMID:
21449614
24.

Metalloprotease type III effectors that specifically cleave JNK and NF-κB.

Baruch K, Gur-Arie L, Nadler C, Koby S, Yerushalmi G, Ben-Neriah Y, Yogev O, Shaulian E, Guttman C, Zarivach R, Rosenshine I.

EMBO J. 2011 Jan 5;30(1):221-31. doi: 10.1038/emboj.2010.297. Epub 2010 Nov 26.

25.

Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models.

Golan L, Gonen E, Yagel S, Rosenshine I, Shpigel NY.

Dis Model Mech. 2011 Jan;4(1):86-94. doi: 10.1242/dmm.005777. Epub 2010 Oct 19.

26.

Essential role of neutrophils but not mammary alveolar macrophages in a murine model of acute Escherichia coli mastitis.

Elazar S, Gonen E, Livneh-Kol A, Rosenshine I, Shpigel NY.

Vet Res. 2010 Jul-Aug;41(4):53. doi: 10.1051/vetres/2010025. Epub 2010 Apr 26.

27.

The type III secretion effector NleE inhibits NF-kappaB activation.

Nadler C, Baruch K, Kobi S, Mills E, Haviv G, Farago M, Alkalay I, Bartfeld S, Meyer TF, Ben-Neriah Y, Rosenshine I.

PLoS Pathog. 2010 Jan 29;6(1):e1000743. doi: 10.1371/journal.ppat.1000743.

28.

EspM inhibits pedestal formation by enterohaemorrhagic Escherichia coli and enteropathogenic E. coli and disrupts the architecture of a polarized epithelial monolayer.

Simovitch M, Sason H, Cohen S, Zahavi EE, Melamed-Book N, Weiss A, Aroeti B, Rosenshine I.

Cell Microbiol. 2010 Apr 1;12(4):489-505. doi: 10.1111/j.1462-5822.2009.01410.x. Epub 2009 Nov 12.

PMID:
19912240
29.

Neutrophil recruitment in endotoxin-induced murine mastitis is strictly dependent on mammary alveolar macrophages.

Elazar S, Gonen E, Livneh-Kol A, Rosenshine I, Shpigel NY.

Vet Res. 2010 Jan-Feb;41(1):10. doi: 10.1051/vetres/2009058. Epub 2009 Oct 14.

30.

Imaging the assembly, structure and activity of type III secretion systems.

Enninga J, Rosenshine I.

Cell Microbiol. 2009 Oct;11(10):1462-70. doi: 10.1111/j.1462-5822.2009.01360.x. Epub 2009 Jul 20. Review.

PMID:
19622097
31.

E. coli transports aggregated proteins to the poles by a specific and energy-dependent process.

Rokney A, Shagan M, Kessel M, Smith Y, Rosenshine I, Oppenheim AB.

J Mol Biol. 2009 Sep 25;392(3):589-601. doi: 10.1016/j.jmb.2009.07.009. Epub 2009 Jul 8.

PMID:
19596340
32.

Mycobacterium avium paratuberculosis invades human small-intestinal goblet cells and elicits inflammation.

Golan L, Livneh-Kol A, Gonen E, Yagel S, Rosenshine I, Shpigel NY.

J Infect Dis. 2009 Feb 1;199(3):350-4. doi: 10.1086/596033.

PMID:
19133807
33.

Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection.

Sason H, Milgrom M, Weiss AM, Melamed-Book N, Balla T, Grinstein S, Backert S, Rosenshine I, Aroeti B.

Mol Biol Cell. 2009 Jan;20(1):544-55. doi: 10.1091/mbc.E08-05-0516. Epub 2008 Nov 5. Erratum in: Mol Biol Cell. 2009 May;20(10):2638.

34.

Mutational analysis of the locus of enterocyte effacement-encoded regulator (Ler) of enteropathogenic Escherichia coli.

Yerushalmi G, Nadler C, Berdichevski T, Rosenshine I.

J Bacteriol. 2008 Dec;190(23):7808-18. doi: 10.1128/JB.00663-08. Epub 2008 Oct 3.

35.

Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule.

Shifrin Y, Peleg A, Ilan O, Nadler C, Kobi S, Baruch K, Yerushalmi G, Berdichevsky T, Altuvia S, Elgrably-Weiss M, Abe C, Knutton S, Sasakawa C, Ritchie JM, Waldor MK, Rosenshine I.

J Bacteriol. 2008 Jul;190(14):5063-74. doi: 10.1128/JB.00440-08. Epub 2008 May 23.

36.

Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli.

Grinberg N, Elazar S, Rosenshine I, Shpigel NY.

Infect Immun. 2008 Jun;76(6):2802-7. doi: 10.1128/IAI.00051-08. Epub 2008 Apr 14.

37.

Host-microbe interactions: bacteria.

Meyer TF, Rosenshine I.

Curr Opin Microbiol. 2008 Feb;11(1):1-2. doi: 10.1016/j.mib.2008.01.007. Epub 2008 Mar 7. No abstract available.

PMID:
18314379
38.

Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli.

Mills E, Baruch K, Charpentier X, Kobi S, Rosenshine I.

Cell Host Microbe. 2008 Feb 14;3(2):104-13. doi: 10.1016/j.chom.2007.11.007.

39.

Mammary pathogenic Escherichia coli.

Shpigel NY, Elazar S, Rosenshine I.

Curr Opin Microbiol. 2008 Feb;11(1):60-5. doi: 10.1016/j.mib.2008.01.004. Epub 2008 Mar 4. Review.

PMID:
18291708
40.

Small RNAs encoded within genetic islands of Salmonella typhimurium show host-induced expression and role in virulence.

Padalon-Brauch G, Hershberg R, Elgrably-Weiss M, Baruch K, Rosenshine I, Margalit H, Altuvia S.

Nucleic Acids Res. 2008 Apr;36(6):1913-27. doi: 10.1093/nar/gkn050. Epub 2008 Feb 11.

41.

Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis.

Gonen E, Vallon-Eberhard A, Elazar S, Harmelin A, Brenner O, Rosenshine I, Jung S, Shpigel NY.

Cell Microbiol. 2007 Dec;9(12):2826-38. Epub 2007 Jun 29.

PMID:
17608742
42.

Structure of GrlR and the implication of its EDED motif in mediating the regulation of type III secretion system in EHEC.

Jobichen C, Li M, Yerushalmi G, Tan YW, Mok YK, Rosenshine I, Leung KY, Sivaraman J.

PLoS Pathog. 2007 May 18;3(5):e69.

43.

Identification and characterization of NleI, a new non-LEE-encoded effector of enteropathogenic Escherichia coli (EPEC).

Li M, Rosenshine I, Yu HB, Nadler C, Mills E, Hew CL, Leung KY.

Microbes Infect. 2006 Nov-Dec;8(14-15):2890-8. Epub 2006 Oct 16.

PMID:
17097322
44.

DeoT, a DeoR-type transcriptional regulator of multiple target genes.

Elgrably-Weiss M, Schlosser-Silverman E, Rosenshine I, Altuvia S.

FEMS Microbiol Lett. 2006 Jan;254(1):141-8.

45.
46.

Identification of an Escherichia coli operon required for formation of the O-antigen capsule.

Peleg A, Shifrin Y, Ilan O, Nadler-Yona C, Nov S, Koby S, Baruch K, Altuvia S, Elgrably-Weiss M, Abe CM, Knutton S, Saper MA, Rosenshine I.

J Bacteriol. 2005 Aug;187(15):5259-66.

47.

Role of type III secretion in Edwardsiella tarda virulence.

Tan YP, Zheng J, Tung SL, Rosenshine I, Leung KY.

Microbiology. 2005 Jul;151(Pt 7):2301-13.

PMID:
16000720
48.

Ler is a negative autoregulator of the LEE1 operon in enteropathogenic Escherichia coli.

Berdichevsky T, Friedberg D, Nadler C, Rokney A, Oppenheim A, Rosenshine I.

J Bacteriol. 2005 Jan;187(1):349-57.

49.

Identification of Salmonella typhimurium genes responsible for interference with peptide presentation on MHC class I molecules: Deltayej Salmonella mutants induce superior CD8+ T-cell responses.

Qimron U, Madar N, Mittrücker HW, Zilka A, Yosef I, Bloushtain N, Kaufmann SH, Rosenshine I, Apte RN, Porgador A.

Cell Microbiol. 2004 Nov;6(11):1057-70.

PMID:
15469434
50.

Comparative proteomic analysis of extracellular proteins of enterohemorrhagic and enteropathogenic Escherichia coli strains and their ihf and ler mutants.

Li M, Rosenshine I, Tung SL, Wang XH, Friedberg D, Hew CL, Leung KY.

Appl Environ Microbiol. 2004 Sep;70(9):5274-82.

Supplemental Content

Loading ...
Support Center